Consolidated Balance Sheet (Unaudited) - USD ($) $ in Millions	Sep. 30, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents	$ 42	$ 899
Trade accounts and other receivables (net of allowance of $9 at September 30, 2018 and $9 at December 31, 2017)	883	976
Inventories	153	113
Assets held for sale (Note 4)	664	7
Other current assets and deferred charges	242	184
Total current assets	1,984	2,179
Investments	7,427	6,552
Property, plant, and equipment	39,953	39,513
Accumulated depreciation and amortization	(11,279)	(11,302)
Property, plant, and equipment – net	28,674	28,211
Intangible assets – net of accumulated amortization	8,324	8,791
Regulatory assets, deferred charges, and other	744	619
Total assets	47,153	46,352
Current liabilities:
Accounts payable	739	978
Liabilities held for sale (Note 4)	49	0
Accrued liabilities	1,117	1,167
Commercial paper	823	0
Long-term debt due within one year	33	501
Total current liabilities	2,761	2,646
Long-term debt	21,409	20,434
Deferred income tax liabilities	1,648	3,147
Regulatory liabilities, deferred income, and other	4,376	3,950
Contingent liabilities (Note 13)
Stockholders’ equity:
Preferred Stock (Note 11)	35	0
Common stock ($1 par value; 1,470 million shares authorized at September 30, 2018 and 960 million shares authorized at December 31, 2017; 1,245 million shares issued at September 30, 2018 and 861 million shares issued at December 31, 2017)	1,245	861
Capital in excess of par value	24,680	18,508
Retained deficit	(9,018)	(8,434)
Accumulated other comprehensive income (loss)	(291)	(238)
Treasury stock, at cost (35 million shares of common stock)	(1,041)	(1,041)
Total stockholders’ equity	15,610	9,656
Noncontrolling interests in consolidated subsidiaries	1,349	6,519
Total equity	16,959	16,175
Total liabilities and equity	$ 47,153	$ 46,352